During the corresponding time, Bio Techne Corp recorded a revenue increase by 1.06 % year on year, sequentially revenue grew by 3.18 %. While revenue at the Bio Techne Corp's corporate clients
Bio Techne's Comment on Sales, Marketing and Customers
Bio-Techne Corporation operates in the research market, providing biological content and targeting diagnostics and related markets. Its Protein Sciences segment accounted for approximately 72% of net sales in fiscal 2026 and comprises the Reagent Solutions and Analytical Solutions divisions. The Reagent Solutions division supplies specialized proteins, antibodies, small molecules, tissue culture sera, and cell selection technologies used by life science researchers and companies developing diagnostics and therapeutics, including cell- and gene-based therapies. Key product brands include R&D Systems, Tocris Biosciences, and Novus Biologicals. Bio-Techne's customers include life science researchers and companies such as B-MoGen Technologies, Fresenius Kabi, Quad Technologies, and Wilson Wolf. The company emphasizes collaborations with key opinion leaders and expanding global sales and distribution channels to improve customer experience and market reach.
Bio Techne’s Comment on Sales, Marketing and Customers
Bio-Techne Corporation operates in the research market, providing biological content and targeting diagnostics and related markets. Its Protein Sciences segment accounted for approximately 72% of net sales in fiscal 2026 and comprises the Reagent Solutions and Analytical Solutions divisions. The Reagent Solutions division supplies specialized proteins, antibodies, small molecules, tissue culture sera, and cell selection technologies used by life science researchers and companies developing diagnostics and therapeutics, including cell- and gene-based therapies. Key product brands include R&D Systems, Tocris Biosciences, and Novus Biologicals. Bio-Techne's customers include life science researchers and companies such as B-MoGen Technologies, Fresenius Kabi, Quad Technologies, and Wilson Wolf. The company emphasizes collaborations with key opinion leaders and expanding global sales and distribution channels to improve customer experience and market reach.
Sources:
Bio techne Corp’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Bio techne Corp’s corporate clients.
For your research, we’ve provided 9 tables on Bio techne Corp corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
306.71 %